Intrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review
- 1Interdisciplinary Department of Medicine, School of Medicine, University of Bari Aldo Moro, Bari, Italy
- 2Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro Bari, Italy
Abstract
Background: Thyroid nodules are highly prevalent in the general population, yet their diagnostic assessment may require accurate differential diagnosis in patients with hematologic malignancies. In this context, immune dysregulation, prior cytotoxic therapies, and the potential for atypical extramedullary involvement may confound conventional risk stratification algorithms. Although ultrasonography remains the first-line imaging modality, fine-needle aspiration with ancillary studies is often required for definitive characterization.
Case report: A 47-year-old woman with relapsed multiple myeloma, previously treated with multiagent chemotherapy, radiotherapy, and autologous stem cell transplantation, was evaluated for biochemical and clinical disease progression. Bone marrow biopsy demonstrated no evidence of plasma cell infiltration. However, 18F-fluorodeoxyglucose positron emission tomography/computed tomography identified focal hypermetabolic uptake in the right thyroid lobe. Dedicated neck ultrasonography revealed a 26-mm solid, markedly hypoechoic nodule with peri-nodular vascularity and without definitive sonographic features of papillary thyroid cancer. Given the discordance between imaging findings and marrow status, ultrasound-guided fine-needle aspiration was performed. Cytologic evaluation demonstrated numerous atypical plasma cells, and immunocytochemistry confirmed lambda light chain restriction, consistent with clonal plasma cell proliferation. These findings established intrathyroidal involvement by multiple myeloma, representing an isolated extramedullary relapse in the absence of bone marrow disease.
Discussion: Intrathyroidal manifestation of multiple myeloma is rare but clinically significant. In patients with systemic malignancies, fluorodeoxyglucose-avid thyroid nodules should prompt consideration of secondary involvement, even when bone marrow evaluation is negative. Conventional ultrasound-based risk stratification systems are primarily designed to detect epithelial thyroid malignancies and may fail to identify nonepithelial neoplasms. Cytologic assessment supplemented by immunophenotypic analysis remains essential for accurate diagnosis.
Conclusion: This case highlights the importance of integrating clinical history, functional imaging, cytopathology, and immunocytochemistry to avoid diagnostic pitfalls and to guide appropriate oncologic management.
Related
- Case Report: SAPHO syndrome mimicking osseous relapse after haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia
- Steroid-resistant Relapse of Autoimmune Pancreatitis with Marked Main Pancreatic Duct Dilatation Mimicking Multifocal Pancreatic Cancer
- GENERATION OF VIRUS-SPECIFIC T CELLS EXPRESSING A CD19 CAR (VST.CD19 CAR-T) FOR TREATMENT OF VIRAL INFECTIONS AND B CELL NEOPLASIA RELAPSE POST HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
- Subjective Sleep Quality in Relation to Relapse Status in Relapsing-Remitting Multiple Sclerosis: A Propensity Score—Matched Nested Case—Control Analysis
- Anti‐CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity (PIRA) in People With Multiple Sclerosis
BibTeX
@article{triggiani2026intrathyroidal,
title = {{Intrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review}},
author = {Domenico Triggiani and Giuseppe Lisco and Giuseppina Renzulli and Mario Della Mura and Vincenzo Triggiani},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
month = jul,
doi = {10.1016/j.aed.2026.06.011},
url = {https://doi.org/10.1016/j.aed.2026.06.011},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Intrathyroidal Relapse of Multiple Myeloma Mimicking Primary Thyroid Neoplasia: A Case Report and Literature Review
AU - Domenico Triggiani
AU - Giuseppe Lisco
AU - Giuseppina Renzulli
AU - Mario Della Mura
AU - Vincenzo Triggiani
PY - 2026
DA - 2026/07/01
JO - AACE Endocrinology and Diabetes
DO - 10.1016/j.aed.2026.06.011
UR - https://doi.org/10.1016/j.aed.2026.06.011
AB - Background: Thyroid nodules are highly prevalent in the general population, yet their diagnostic assessment may require accurate differential diagnosis in patients with hematologic malignancies. In this context, immune dysregulation, prior cytotoxic therapies, and the potential for atypical extramedullary involvement may confound conventional risk stratification algorithms. Although ultrasonography remains the first-line imaging modality, fine-needle aspiration with ancillary studies is often required for definitive characterization. Case report: A 47-year-old woman with relapsed multiple myeloma, previously treated with multiagent chemotherapy, radiotherapy, and autologous stem cell transplantation, was evaluated for biochemical and clinical disease progression. Bone marrow biopsy demonstrated no evidence of plasma cell infiltration. However, 18F-fluorodeoxyglucose positron emission tomography/computed tomography identified focal hypermetabolic uptake in the right thyroid lobe. Dedicated neck ultrasonography revealed a 26-mm solid, markedly hypoechoic nodule with peri-nodular vascularity and without definitive sonographic features of papillary thyroid cancer. Given the discordance between imaging findings and marrow status, ultrasound-guided fine-needle aspiration was performed. Cytologic evaluation demonstrated numerous atypical plasma cells, and immunocytochemistry confirmed lambda light chain restriction, consistent with clonal plasma cell proliferation. These findings established intrathyroidal involvement by multiple myeloma, representing an isolated extramedullary relapse in the absence of bone marrow disease. Discussion: Intrathyroidal manifestation of multiple myeloma is rare but clinically significant. In patients with systemic malignancies, fluorodeoxyglucose-avid thyroid nodules should prompt consideration of secondary involvement, even when bone marrow evaluation is negative. Conventional ultrasound-based risk stratification systems are primarily designed to detect epithelial thyroid malignancies and may fail to identify nonepithelial neoplasms. Cytologic assessment supplemented by immunophenotypic analysis remains essential for accurate diagnosis. Conclusion: This case highlights the importance of integrating clinical history, functional imaging, cytopathology, and immunocytochemistry to avoid diagnostic pitfalls and to guide appropriate oncologic management.
SN - 3050-9157
ER -